QR-059

N/A

Report date: 2025/06/26 16:55:04
NME

Base Information

Drug NameQR-059
Drug Alias NameQR-059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemoglobinuria, ParoxysmalGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Createrna Science and Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Createrna Science and Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, ParoxysmalGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A